Health & Medication Blog
Evidence-based guides, comparisons, and practical advice for GLP-1 medications, TRT, HRT, mental health, and more. Updated regularly with the latest research, FDA news, and pricing.
Adderall Shortage 2026: Why It Continues and the Best Alternatives Available
The Adderall shortage continues into 2026 due to DEA manufacturing quotas and surging demand. Discover the most effective alternatives — including generic Vyvanse at $35–50/month, Concerta, Azstarys, Strattera, and Qelbree — with a detailed comparison table.
Switching from Adderall to Vyvanse: Complete Dose Conversion and Transition Guide
Switching from Adderall to Vyvanse is increasingly common due to the ongoing shortage and Vyvanse's smoother profile. This guide covers dose conversion, timeline, side effects, and cost — including generic Vyvanse now at $35–50/month.
Adult ADHD Medication Guide 2026: Comparing Every Treatment Option
This 2026 guide compares all adult ADHD medications — amphetamine stimulants, methylphenidate stimulants, and non-stimulants — with a detailed comparison table, dosing information, cost analysis, and guidance on choosing the right treatment.
Strattera vs Stimulants for ADHD: When Non-Stimulant Treatment Is the Better Choice
Strattera offers 24/7 ADHD coverage without abuse potential. Learn when non-stimulants like Strattera or Qelbree are the better choice — especially for patients with anxiety, substance use history, or the need for continuous symptom control.
Best Online ADHD Treatment Platforms in 2026: Telehealth Options Compared
Online ADHD treatment has evolved rapidly — but 2026 DEA rules now require an in-person visit for new stimulant prescriptions. Compare Done, Cerebral, Talkiatry, ADHD Online, and Klarity to find the right fit.
Planning a medication switch?
Use our free calculator to get a personalized switching plan, dose mapping, and cost comparison.
Try the MedSwitcher CalculatorResearch without missing the move
Get the important GLP-1 updates, not more noise
We’ll send the high-signal stuff only: pricing changes, shortages, and new switch guidance worth acting on.
- Price and access changes
- New medication comparisons
- Actionable switch guidance
No spam. Unsubscribe anytime. We never share your email.